Clinical Trials Directory

Trials / Unknown

UnknownNCT02430025

Fujian Province Cardiovascular Diseases Study

Status
Unknown
Phase
Study type
Observational
Enrollment
8,000 (estimated)
Sponsor
Fujian Provincial Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This proposal delineates a research plan to collect blood from the patients with cardiovascular diseases for the purpose of establishing a molecular biological bank registry. The Fujian provincial hospital will enroll 8,000 patients.The blood collected will be processed to create a repository of molecular biological plasma. Along with a sample of blood collected from individual patients, a concise general medical history, demographic data, electrocardiographic data, echocardiographic data, and laboratory data will be collected. A short interview will take place after enrollment during the outpatient visit or hospital stay, or may be conducted via phone call after enrollment. All the clinical data gathered will be compiled in Fujian provincial hospital center database, and would be stored in a format where a culmination of clinical findings, i.e. representing a disease of interest, can be used to search the database to identify the blood samples of all patients with such characteristics for further study.

Detailed description

The study is to commence on May 1st 2015 and is to be completed within 3-5 years. The targeted number of patients to be enrolled is 8,000. All patients have the history of cardiovascular diseases, will be eligible to be enrolled. Patients inclusion criteria are as follows, once informed consent is obtained: 1. Males or females at least 18 years old. 2. Patient has not been previously enrolled in the molecular biological bank registry of the Fujian provincial hospital. 3. Patient able to give informed consent. 4. Any patient with history of cardiovascular diseases (If a subject reports history of cardiovascular diseases at another facility, outside records will be obtained to confirm the diagnosis.

Conditions

Timeline

Start date
2015-06-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2015-04-29
Last updated
2015-04-29

Source: ClinicalTrials.gov record NCT02430025. Inclusion in this directory is not an endorsement.